• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似宫颈病变病例中 HPV16 的 E6 基因鉴定及其 L1 蛋白与 的活性成分对接研究。

Identification of HPV16's E6 gene in suspected cases of cervical lesions and docking Study of its L1 protein with active components of .

机构信息

Microbiology unit, Department of medical laboratory science faculty of allied health science, Bayero University kano, Nigeria, P.M.B 3011, Kano, Nigeria.

Federal Medical Centre Katsina, PMB 2121, Katsina, Nigeria.

出版信息

Afr Health Sci. 2022 Mar;22(1):98-105. doi: 10.4314/ahs.v22i1.13.

DOI:10.4314/ahs.v22i1.13
PMID:36032471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9382523/
Abstract

BACKGROUND

HPV 16 is the primary etiologic agent of cervical cancer and the presence of L1 and E6 oncoproteins are largely responsible for its virulence. It was the objective of this study to identify HPV16 isolates from suspected cases of cervical cancer at Specialist Hospital Sokoto and Sir Yahaya Memorail Hospiatal Birnin Kebbi, Nigeria and also to identify potent HPV16's L1 protein inhibitor using in silico analysis.

METHODS

A total of 144 cervical samples consisting of 21 low grade squamous intraepithelial lesion, 6 high grade lesion and 117 negative pap smears were collected. The samples were subjected for molecular detection using PCR targeting E6 gene of the virus. Data generated for the molecular prevalence was statistically analyzed using Chi-square method. AutoDock Vina was used to carry out the molecular docking between 2hr5 and Chicoric acid, curcumin and Echinacoside.

RESULTS

Out of the 144 samples, 24 samples were positive for the PCR representing 16.9% molecular prevalence rate. There is statistically significant association between cyto-diagnoses and presence of HPV16 (P < 0.05). Docking analysis showed that the Chicoric acid components of Echinacea purpurae have strong binding affinity (-8.7 kcal/mol) to the L1 protein of the HPV.

CONCLUSION

This study provides data on HPV 16 epidemiology in northern Nigeria, and also provides novel evidence for consideration on certain interacting residues, when synthesizing Anti-HPV compounds in the wet lab.

摘要

背景

HPV16 是宫颈癌的主要病因,其 L1 和 E6 癌蛋白的存在在很大程度上与其毒力有关。本研究的目的是鉴定尼日利亚索科托专家医院和锡亚亚·雅哈亚纪念医院疑似宫颈癌病例中的 HPV16 分离株,并利用计算机分析鉴定有效的 HPV16 L1 蛋白抑制剂。

方法

共采集 144 例宫颈样本,包括 21 例低级别鳞状上皮内病变、6 例高级别病变和 117 例阴性巴氏涂片。采用针对病毒 E6 基因的 PCR 法对样本进行分子检测。采用卡方检验对分子流行率数据进行统计学分析。利用 AutoDock Vina 对 Chicoric acid、curcumin 和 Echinacoside 与 2hr5 之间进行分子对接。

结果

144 个样本中,24 个样本的 PCR 呈阳性,代表 16.9%的分子流行率。细胞诊断与 HPV16 之间存在统计学显著关联(P < 0.05)。对接分析表明,紫锥菊 Chicoric acid 成分与 HPV 的 L1 蛋白具有很强的结合亲和力(-8.7 kcal/mol)。

结论

本研究提供了尼日利亚北部 HPV16 流行病学的数据,并且在湿实验室合成抗 HPV 化合物时,为某些相互作用的残基提供了新的考虑证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a8/9382523/baba6c27c4df/AFHS2201-0098Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a8/9382523/b9d01aed63a9/AFHS2201-0098Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a8/9382523/3f2fddb4c6a3/AFHS2201-0098Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a8/9382523/360c8be0d91b/AFHS2201-0098Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a8/9382523/baba6c27c4df/AFHS2201-0098Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a8/9382523/b9d01aed63a9/AFHS2201-0098Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a8/9382523/3f2fddb4c6a3/AFHS2201-0098Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a8/9382523/360c8be0d91b/AFHS2201-0098Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a8/9382523/baba6c27c4df/AFHS2201-0098Fig4.jpg

相似文献

1
Identification of HPV16's E6 gene in suspected cases of cervical lesions and docking Study of its L1 protein with active components of .疑似宫颈病变病例中 HPV16 的 E6 基因鉴定及其 L1 蛋白与 的活性成分对接研究。
Afr Health Sci. 2022 Mar;22(1):98-105. doi: 10.4314/ahs.v22i1.13.
2
Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.使用实时聚合酶链反应分析对ThinPrep巴氏试验剩余材料中的人乳头瘤病毒16 E6和E7 DNA及RNA进行定量分析。
Cancer. 2002 Apr 15;94(8):2199-210. doi: 10.1002/cncr.10439.
3
E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma.E2/E6 比值和 L1 免疫反应作为生物标志物,用于确定 HPV16 阳性的高级别鳞状上皮内病变(CIN2 和 3)和宫颈鳞状细胞癌。
J Gynecol Oncol. 2018 May;29(3):e38. doi: 10.3802/jgo.2018.29.e38. Epub 2018 Feb 1.
4
HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.HPV16 E6 变体:频率、与 HPV 类型的关联以及鉴定的新型变体的计算机分析。
J Med Virol. 2014 Jun;86(6):968-74. doi: 10.1002/jmv.23924. Epub 2014 Mar 7.
5
HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.中国四川宫颈癌患者中HPV16分离株的HPV流行率、E6序列变异及物理状态
Gynecol Oncol. 2007 Jan;104(1):77-85. doi: 10.1016/j.ygyno.2006.07.016. Epub 2006 Sep 12.
6
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.人乳头瘤病毒16型(HPV - 16)病毒样颗粒L1特异性CD8 + 细胞毒性T淋巴细胞(CTL)在杀死宫颈癌患者自体HPV - 16阳性肿瘤细胞方面与E7特异性CD8 + CTL同样有效:对基于L1树突状细胞的治疗性疫苗的启示。
J Virol. 2009 Jul;83(13):6779-89. doi: 10.1128/JVI.02443-08. Epub 2009 Apr 22.
7
Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.俄罗斯宫颈癌患者中针对16型和18型人乳头瘤病毒癌蛋白E6和E7的抗体
Int J Cancer. 2000 Feb 1;85(3):313-8. doi: 10.1002/(sici)1097-0215(20000201)85:3<313::aid-ijc3>3.0.co;2-w.
8
Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions.基于E6和L1基因的突尼斯宫颈病变女性人乳头瘤病毒(HPV)16和HPV18变体的系统发育与分类
Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3361-3366. doi: 10.31557/APJCP.2018.19.12.3361.
9
Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women.人乳头瘤病毒16/18 E6和E7癌蛋白在HIV阳性女性高级别宫颈鳞状上皮内病变中的免疫表达
Genet Mol Res. 2016 Feb 19;15(1):gmr7220. doi: 10.4238/gmr.15017220.
10
HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.用于 HPV 阳性女性管理的 HPV 基因型测定和 E6/E7mRNA 检测。
Virol J. 2018 Mar 27;15(1):52. doi: 10.1186/s12985-018-0957-z.

引用本文的文献

1
Sexual reproductive health, NCDs and infectious diseases.性生殖健康、非传染性疾病和传染病。
Afr Health Sci. 2022 Mar;22(1):i-v. doi: 10.4314/ahs.v22i1.1.

本文引用的文献

1
Annexin A2 extracellular translocation and virus interaction: A potential target for antivirus-drug discovery.膜联蛋白 A2 的细胞外转位与病毒相互作用:抗病毒药物发现的潜在靶点。
Rev Med Virol. 2019 May;29(3):e2038. doi: 10.1002/rmv.2038. Epub 2019 Feb 11.
2
Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the out-patient clinics of a university teaching hospital in Lagos, Nigeria.尼日利亚拉各斯一家大学教学医院门诊就诊女性中生殖器高危型人乳头瘤病毒感染的患病率及危险因素
Pan Afr Med J. 2017 Nov 14;28:227. doi: 10.11604/pamj.2017.28.227.13979. eCollection 2017.
3
Molecular epidemiology and phylogenetic analysis of human papillomavirus infection in women with cervical lesions and cancer from the coastal region of Ecuador.
厄瓜多尔沿海地区宫颈病变和癌症女性人乳头瘤病毒感染的分子流行病学及系统发育分析
Rev Argent Microbiol. 2018 Apr-Jun;50(2):136-146. doi: 10.1016/j.ram.2017.06.004. Epub 2017 Nov 20.
4
Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis.通过对接分析阐明天然抑制剂与HPV-16 E6癌蛋白的分子相互作用
Genomics Inform. 2014 Jun;12(2):64-70. doi: 10.5808/GI.2014.12.2.64. Epub 2014 Jun 30.
5
Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis.人乳头瘤病毒 16 型通过肌动蛋白依赖性、网格蛋白和脂筏非依赖性内吞作用进入细胞。
PLoS Pathog. 2012;8(4):e1002657. doi: 10.1371/journal.ppat.1002657. Epub 2012 Apr 19.
6
The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1.聚阴离子型人类免疫缺陷病毒 1 抑制剂的兴起与衰落。
Antiviral Res. 2011 Jun;90(3):168-82. doi: 10.1016/j.antiviral.2011.03.176. Epub 2011 Mar 23.
7
Structural basis of oligosaccharide receptor recognition by human papillomavirus.人乳头瘤病毒通过寡糖受体识别的结构基础。
J Biol Chem. 2011 Jan 28;286(4):2617-24. doi: 10.1074/jbc.M110.160184. Epub 2010 Nov 29.
8
Target cell cyclophilins facilitate human papillomavirus type 16 infection.靶细胞亲环素促进16型人乳头瘤病毒感染。
PLoS Pathog. 2009 Jul;5(7):e1000524. doi: 10.1371/journal.ppat.1000524. Epub 2009 Jul 24.
9
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.AutoDock4 和 AutoDockTools4:具有选择性受体柔性的自动化对接。
J Comput Chem. 2009 Dec;30(16):2785-91. doi: 10.1002/jcc.21256.
10
A docking study of L-chicoric acid with HIV-1 integrase.L-菊苣酸与HIV-1整合酶的对接研究。
J Mol Graph Model. 2009 Jan;27(5):584-9. doi: 10.1016/j.jmgm.2008.09.011. Epub 2008 Oct 2.